Cargando…
Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
BACKGROUND: Intensive evidence has highlighted the effect of aberrant alternative splicing (AS) events on cancer progression when triggered by dysregulation of the SR protein family. Nonetheless, the underlying mechanism in breast cancer (BRCA) remains elusive. Here we sought to explore the molecula...
Autores principales: | Du, Jun-Xian, Luo, Yi-Hong, Zhang, Si-Jia, Wang, Biao, Chen, Cong, Zhu, Gui-Qi, Zhu, Ping, Cai, Cheng-Zhe, Wan, Jing-Lei, Cai, Jia-Liang, Chen, Shi-Ping, Dai, Zhi, Zhu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122567/ https://www.ncbi.nlm.nih.gov/pubmed/33992102 http://dx.doi.org/10.1186/s13046-021-01978-8 |
Ejemplares similares
-
SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
por: Sheng, Junxiu, et al.
Publicado: (2018) -
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019) -
Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides
por: Guo, Jihua, et al.
Publicado: (2018) -
SRSF1-mediated alternative splicing is required for spermatogenesis
por: Lei, Wen-Long, et al.
Publicado: (2023) -
Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data
por: Du, Jun-Xian, et al.
Publicado: (2021)